Cyagen biosciences:1230918 [18-009393]
Ended Purchase Order Awarded Last action
- Contract number
- 75N95018P00434
- Awardee
-
Cyagen Biosciences Inc. UEI EL2WH3GC3LD5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Opportunity
-
- NIHDA201800341 Solicitation number
- Cyagen Cardiac-Inducible AdCy8 TurboKnockout Mouse Strain Award Notice · Posted Jul 19, 2018
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Baltimore, MD 21224, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$30,915 | |
| Original award | $30,915 |
Quick answers
Who was awarded contract 75N95018P00434?
75N95018P00434 was awarded to Cyagen Biosciences Inc. by National Institute on Drug Abuse (National Institutes of Health) on July 26, 2018.
How much is contract 75N95018P00434 worth?
The government has obligated $0 on 75N95018P00434.
Was contract 75N95018P00434 competed?
The extent of competition for 75N95018P00434 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award